Gabrb1^{tm1d(KOMP)Wtsi}
Targeted Allele Detail

Summary

• Symbol: Gabrb1^{tm1d(KOMP)Wtsi}
• Name: gamma-aminobutyric acid type A receptor subunit beta 1; targeted mutation 1d, Wellcome Trust Sanger Institute
• MGI ID: MGI:6509465
• Gene: Gabrb1 Location: Chr5:71815456-72306380 bp, + strand Genetic Position: Chr5, 38.18 cM
• Alliance: Gabrb1^{tm1d(KOMP)Wtsi} page
• IMPC: Gabrb1 gene page

Mutation origin

• Germline Transmission: Earliest citation of germline transmission: J:302682
• Parent Cell Line: JM8A3.N1 (ES Cell)
• Strain of Origin: C57BL/6N-A^tm1Brd
• Project Collection: KOMP-CSD

Mutation description

• Allele Type: Targeted (Null/knockout)
• Mutation: Intragenic deletion
• Mutation details: The L1L2_Bact_P cassette was inserted at position 37372977 of Chromosome 17 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 37374573. The critical exon(s) is/are thus flanked by loxP sites. A null/knockout allele was created by flp and cre recombinase expression in mice carrying this allele to remove the lacZ sequence, neo selection cassette and the loxP-flanked critical exon(s). Further information on targeting strategies used for this and other IKMC alleles can be found at http://www.informatics.jax.org/mgihome/nomen/IKMC_schematics.shtml (J:302682)

Find Mice (IMSR)

• Mouse strains and cell lines available from the International Mouse Strain Resource (IMSR)
• Carrying this Mutation: Mouse Strains: 0 strains available Cell Lines: 0 lines available
• Carrying any Gabrb1 Mutation: 29 strains or lines available

References

• Original: J:302682 Dalby NO, et al., Silencing of spontaneous activity at alpha4beta1/3delta GABAA receptors in hippocampal granule cells reveals different ligand pharmacology. Br J Pharmacol. 2020 Sep;177(17):3975-3990
• All: 1 reference(s)